Raggenbass-Frischknecht Axelle, Philippe Jacques, Gastaldi Giacomo
Service de médecine de premier recours, Département de médecine communautaire, de premier recours et des urgences, HUG, 1211 Genève 14.
Service d'endocrinologie, diabétologie, hypertension et nutrition, HUG, 1211 Genève 14.
Rev Med Suisse. 2017 May 31;13(565):1150-1157.
Metabolic surgery is a serious option to treat type 2 diabetes. The latest guidelines consider surgery as one of the first option, especially in patients suffering from severe obesity or those who have uncontrolled diabetes. However, the radicality of metabolic surgery limits its prescription and is difficult to handle. Indeed, criteria of success remain insufficently understood in order to help caregivers to rigorously select the right candidates. This article proposes a review of the literature on the risks and benefits of metabolic surgery for the diabetic obese patient.
代谢手术是治疗2型糖尿病的一种重要选择。最新指南将手术视为首选方案之一，尤其是对于患有严重肥胖症或糖尿病控制不佳的患者。然而，代谢手术的激进性限制了其应用，且操作难度较大。事实上，为帮助医护人员严格筛选合适的患者，成功标准仍未得到充分理解。本文对有关代谢手术对糖尿病肥胖患者的风险和益处的文献进行了综述。
